About Alzheon, Inc. | Preserving Future Memories

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
111 Speen Street, Suite 306, Framingham, MA 01701, US
Description
Information
Alzheon, Inc. is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders. Our lead Alzheimer’s clinical candidate, ALZ-801, is an oral small molecule prodrug of tramiprosate that fully blocks formation of neurotoxic soluble amyloid oligomers in the brain. ALZ-801 is an easy-to-take tablet that builds on the safety and efficacy profile of its active compound tramiprosate, which has been evaluated in clinical trials involving over 2,000 Alzheimer’s patients. Our clinical expertise and technology platform are focused on developing drug candidates using a precision medicine approach based on individual genetic and biological information to advance therapies with the greatest impact for patients. www.alzheon.com

Alzheon, Inc. | Preserving Future Memories Alternatives

Frequently Asked Questions about Alzheon, Inc. | Preserving Future Memories

What is Alzheon, Inc. | Preserving Future Memories email format?

The widely used Alzheon, Inc. | Preserving Future Memories email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Alzheon, Inc. | Preserving Future Memories customer service number?

To contact Alzheon, Inc. | Preserving Future Memories customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more